Louisiana State University

LSU Digital Commons
Faculty Publications

School of Animal Sciences

10-1-2002

Identification of a streptolysin S-associated gene cluster and its
role in the pathogenesis of Streptococcus iniae disease
Jeffrey D. Fuller
Mount Sinai Hospital of University of Toronto

Alvin C. Camus
Mount Sinai Hospital of University of Toronto

Carla L. Duncan
Mount Sinai Hospital of University of Toronto

Victor Nizet
Mount Sinai Hospital of University of Toronto

Darrin J. Bast
Mount Sinai Hospital of University of Toronto

See next page for additional authors

Follow this and additional works at: https://digitalcommons.lsu.edu/animalsciences_pubs

Recommended Citation
Fuller, J., Camus, A., Duncan, C., Nizet, V., Bast, D., Thune, R., Low, D., & De Azavedo, J. (2002).
Identification of a streptolysin S-associated gene cluster and its role in the pathogenesis of
Streptococcus iniae disease. Infection and Immunity, 70 (10), 5730-5739. https://doi.org/10.1128/
IAI.70.10.5730-5739.2002

This Article is brought to you for free and open access by the School of Animal Sciences at LSU Digital Commons.
It has been accepted for inclusion in Faculty Publications by an authorized administrator of LSU Digital Commons.
For more information, please contact ir@lsu.edu.

Authors
Jeffrey D. Fuller, Alvin C. Camus, Carla L. Duncan, Victor Nizet, Darrin J. Bast, Ronald L. Thune, Donald E.
Low, and Joyce C.S. De Azavedo

This article is available at LSU Digital Commons: https://digitalcommons.lsu.edu/animalsciences_pubs/1428

INFECTION AND IMMUNITY, Oct. 2002, p. 5730–5739
0019-9567/02/$04.00⫹0 DOI: 10.1128/IAI.70.10.5730–5739.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

Vol. 70, No. 10

Identification of a Streptolysin S-Associated Gene Cluster and Its Role
in the Pathogenesis of Streptococcus iniae Disease
Jeffrey D. Fuller,1,2 Alvin C. Camus,3 Carla L. Duncan,2 Victor Nizet,4 Darrin J. Bast,1,2
Ronald L. Thune,3 Donald E. Low,1,2 and Joyce C. S. de Azavedo1,2*
Department of Laboratory Medicine and Pathobiology, University of Toronto,1 and Department of Microbiology, Mount Sinai
Hospital, and Toronto Medical Laboratories, University Health Network,2 Toronto, Ontario, Canada; Department of
Pathological Sciences, School of Veterinary Medicine, Louisiana State University, Baton Rouge, Louisiana3; and
Division of Pediatric Infectious Diseases, University of California, San Diego School of Medicine,
La Jolla, California4

Streptococcus iniae causes meningoencephalitis and death in cultured fish species and soft-tissue infection in
humans. We recently reported that S. iniae is responsible for local tissue necrosis and bacteremia in a murine
subcutaneous infection model. The ability to cause bacteremia in this model is associated with a genetic profile
unique to strains responsible for disease in fish and humans (J. D. Fuller, D. J. Bast, V. Nizet, D. E. Low, and
J. C. S. de Azavedo, Infect. Immun. 69:1994-2000, 2001). S. iniae produces a cytolysin that confers a hemolytic
phenotype on blood agar media. In this study, we characterized the genomic region responsible for S. iniae
cytolysin production and assessed its contribution to virulence. Transposon (Tn917) mutant libraries of
commensal and disease-associated S. iniae strains were generated and screened for loss of hemolytic activity.
Analysis of two nonhemolytic mutants identified a chromosomal locus comprising 9 genes with 73% homology
to the group A streptococcus (GAS) sag operon for streptolysin S (SLS) biosynthesis. Confirmation that the S.
iniae cytolysin is a functional homologue of SLS was achieved by PCR ligation mutagenesis, complementation
of an SLS-negative GAS mutant, and use of the SLS inhibitor trypan blue. SLS-negative sagB mutants were
compared to their wild-type S. iniae parent strains in the murine model and in human whole-blood killing
assays. These studies demonstrated that S. iniae SLS expression is required for local tissue necrosis but does
not contribute to the establishment of bacteremia or to resistance to phagocytic clearance.
Streptococcus iniae is a hemolytic, gram-positive coccus that
causes meningoencephalitis and significant mortality in a variety of commercial fish species, creating a substantial economic
burden for the aquaculture industry (12, 13, 41, 42). S. iniae
also causes fulminant soft-tissue infection in humans, with associated bacteremia, following percutaneous injury acquired
while handling whole fish (48). Although our understanding of
the pathogenicity of this organism is poor, pulsed-field gel
electrophoresis (PFGE) has revealed that strains causing disease in fish and strains causing disease in humans are clonally
related, whereas commensal isolates from nondiseased fish are
genetically diverse (48). We recently reported that this unique
genetic profile was associated with virulence in experimental
model systems. Disease-associated strains caused significant
weight loss and bacteremia in a murine model of subcutaneous infection, exhibited resistance to phagocytic clearance
in human whole blood, and were cytotoxic to human endothelial cells in vitro (19). From these findings we hypothesized that
this unique genetic profile indicated the presence of one or
more virulence determinants important to disease.
One of the few distinguishing phenotypes of S. iniae is the
zone of beta-hemolysis surrounding colonies cultured on blood
agar (42). Hemolysins, or cytolysins, are well-recognized features of many bacterial species, including streptococci, and are

generally associated with damage to the membranes of a variety of mammalian cell types. Examples of streptococcal cytolysins include streptolysin O (SLO) and streptolysin S (SLS) of
group A streptococci (GAS), the beta-hemolysin/cytolysin of
group B streptococci (GBS), and the pneumolysin of Streptococcus pneumoniae, each of which has been implicated as a
virulence factor in animal models of infection (3, 4, 33, 49). In
this investigation, we describe a molecular approach used to
identify the genetic locus responsible for cytolysin production
in S. iniae. The contribution of the S. iniae cytolysin to disease
pathogenesis was examined by using a murine model of subcutaneous infection.
MATERIALS AND METHODS
Bacterial strains, media, and transformation. Bacterial strains used in this
study are listed in Table 1. S. iniae and other gram-positive bacterial strains were
grown in Todd-Hewitt broth (THB) or on Columbia base agar (Difco, Detroit,
Mich.) supplemented with 5% defibrinated sheep erythrocytes (SBA) (Quelab).
Mid-log-phase cells were prepared from overnight cultures that were diluted 1/25
in THB and incubated at 37°C for 3 to 6 h. An optical density measurement of
0.35 to 0.40 at 620 nm, by use of a spectrophotometer (Beckman Instruments,
Fullerton, Calif.), corresponded to mid-log-phase growth (108 CFU). For anaerobic conditions, cultures were incubated in anaerobic jars with an AnaeroGen
pack (Oxoid). Escherichia coli was grown in Luria-Bertani (LB) broth or on LB
agar (Difco). Antibiotics were used at the following concentrations: ampicillin,
100 g/ml; erythromycin (ERY), 5 (for GAS) or 300 (for E. coli MC1061) g/ml;
chloramphenicol (CHL), 2 to 4 (for GAS) or 2.5 (for S. iniae) g/ml. Grampositive strains were rendered competent for transformation by growth in THB
plus 0.6% glycine as described for GBS (18). E. coli MC1061 was rendered
competent by standard methods (11), and E. coli TOP10 competent cells were
obtained from Invitrogen Life Technologies. Plasmids were introduced by electroporation (at 1,500 V; Eppendorf model 2510) and immediately transferred
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TABLE 1. Bacterial strains and plasmids
Description

Bacterial strains
S. iniae
9117
9066
9174
SI sagB.KO.erm
SI sagB.KO.Tn917
GAS
NZ131
NZ131 sagA⌬cat
E. coli
MC1061
TOP10
Plasmids
pTV1OK
pUC19
pVE6007⌬
pCR2.1-TOPO
pSIsagB.KO.erm
pDC123
pSIsagA

Reference or source

Disease-associated blood culture isolate from patient with cellulitis
Commensal isolate from surface of healthy fish
Commensal isolate from surface of healthy fish
Nonhemolytic insertion/deletion mutant of 9117
Nonhemolytic Tn917 mutant of 9174

19
19
This study
This study
This study

T14/M49 clinical isolate from patient with glomerulonephritis; SLS⫹
Nonhemolytic allelic replacement mutant of NZ131

44
Datta et al., Abstr. 6th Ann.
Streptococcal Genetics
Conf. abstr. 132

F⫺ araD139 ⌬(araABC-leu)7696 ⌬lacX74 galU galK hsdR2(rK⫺ mK⫹) mcrB1 rpsL (Strr)
F⫺ mcA ⌬(mrr-hsd RMS-mcrBC) 80 dlacZ ⌬M15 ⌬(lacZ)X74 deoR recA1 araD139
⌬(ara-leu)7697 galU galK rpsL (Strr)end A1 nup G

50
22

repA(Ts)-pWV01(Ts) aphA3 Tn917 (erm)
lacZ␣ bla
Temperature-sensitive derivative of pWV01; Cmr
ColE ori Ampr Kmr lacZ␣
pVE6007⌬ ⫹ 2,782-bp ermB allelic replacement construct
E. coli/streptococcal shuttle vector, JS-3 replicon; Cmr
pDC123 ⫹ 196-bp PCR amplicon of S. iniae sagA

23
Pharmacia
35
Invitrogen
This study
8
This study

into 1 ml of recovery medium (for GAS, THB plus 0.25 M sucrose; for E. coli,
SOC) for 1 to 3 h, at permissive temperatures, prior to antibiotic selection on
agar media. Genomic and plasmid DNAs were extracted by previously described
methods (5, 18, 46).
Primers and DNA sequencing. Oligonucleotide primers are listed in Table 2.
DNA sequences were obtained by using an automated sequencer (ABI Prism;
Applied Biosystems, Oakville, Ontario, Canada) at the Center for Applied
Genomics, DNA Sequencing Facility, Hospital for Sick Children (Toronto, Ontario, Canada). The S. iniae sequence was compared with those in the GenBank
databases by using the BLAST local alignment program of the National Center
for Biotechnology Information, National Institutes of Health (1), and was
aligned and annotated by using Vector NTI (InforMax, Inc.) software.
Tn917 mutagenesis and identification of transposon insertion sites. Insertional mutagenesis of S. iniae strains 9117 and 9174 was performed as described
for Streptococcus mutans by using the temperature-sensitive plasmid pTV1OK,

which harbors the conjugative transposon Tn917 (23). Insertional libraries were
screened on SBA for nonhemolytic (NH) transconjugants, and the genomic
junction sites of Tn917 insertions were identified as follows. The junction site
containing the transposon-associated ermB gene in SINH3, derived from the
disease-associated strain 9117, was cloned as a HindIII fragment in pUC19,
transformed into E. coli MC1061, selected on ERY, and sequenced by using the
ermB R and M13 universal primers. DNA from the insertion sites of the mutants
SINH1, derived from the disease-associated strain 9117, and SI sagB.KO.Tn917,
derived from the commensal strain 9174, was isolated by using a novel PCRbased method described by Karlyshev and colleagues (26). Transposon-specific,
outward-reading primers ltp-1 and rtp-1 were used for the single-primer PCR
amplification of up- and downstream Tn917-junction sites, respectively, from the
genomic DNA template. Reactions utilized Taq DNA polymerase (Invitrogen
Life Technologies) under the following cycling conditions: 2 min at 94°C; 20
cycles of 94°C for 30 s, 57°C for 30 s, and 72°C for 3 min; 30 cycles of 94°C for

TABLE 2. Primer list
Primer

ermB F
ermB R
ltp-1
ltp-2
rtp-1
rtp-2
p1
p2-ascI
Erm-PA
Erm-PB
p3-ecoRI
p4
SI sagA 1156
SI sagA 1352
SK⫹
T7
sagA 1530
sagA 1688
a
b

Sequence

5⬘
5⬘
5⬘
5⬘
5⬘
5⬘
5⬘
5⬘
5⬘
5⬘
5⬘
5⬘
5⬘
5⬘
5⬘
5⬘
5⬘
5⬘

TGCGTCTGACATCTATCTGATTG 3⬘
TTATCTGGAACATCTGTGGTATGG 3⬘
AGAGAGATGTCACCGTCAAG 3⬘
AATGTACAAAATAACAGCGAA 3⬘
CTAAACACTTAAGAGAATTG 3⬘
TAGGCCTTGAAACATTGGTT 3⬘
TGATTTCGTAGTCGCACCTCCG 3⬘
GGCGCGCCCCCGCTTCATCTTGGCTGATTGAC 3⬘a
GGCGCGCCCCGGGCCCAAAATTTGTTTGAT 3⬘a
GGCCGGCCAGTCGGCAGCGACTCATAGAAT 3⬘b
GGCCGGCCCACATTAGTAGGAAACAAGGAGTCG 3⬘b
TAACTGGTTGCGTCGTTGG 3⬘
ATTTGTATAAGGAGGTAAGC 3⬘
AGTGAATTACTTTGGAGCTG 3⬘
GCTCTAGAACTAGTGG 3⬘
TAATACGACTCACTATAGGG 3⬘
ATGTTAAAATTTACTTC 3⬘
TTTACCTGGCGTATAACTTC 3⬘

Underlining indicates AscI site.
Underlining indicates EcoRI site.

Description

Tn917 left, ermB intragenic primer
Tn917 left, ermB intragenic primer
Tn917 left, outward-reading primer
Tn917 left, outward-reading primer
Tn917 right, outward-reading primer
Tn917 right, outward-reading primer
psagB.KO.erm primer
psagB.KO.erm primer
psagB.KO.erm primer
psagB.KO.erm primer
psagB.KO.erm primer
psagB.KO.erm primer
S. iniae sagA primer
S. iniae sagA primer
pVE6007⌬ primer
pVE6007⌬ primer
GAS sagA primer
GAS sagA primer

Downloaded from https://journals.asm.org/journal/iai on 18 January 2022 by 2620:105:b001:1060:86f:667c:32f5:4ae9.

Bacterial strain
or plasmid

FULLER ET AL.

30 s, 45°C for 30 s, and 72° for 2 min; 30 cycles of 94°C for 30 s, 57°C for 30 s,
and 72°C for 2 min; and 72°C for 7 min. Unique amplicons were gel purified with
the QIAEX gel extraction kit (Qiagen) and sequenced by using the corresponding nested outward-reading primers, ltp-2 and rtp-2.
Southern localization of Tn917-junction fragments. Genomic DNA (⬃1 g)
was digested with HindIII, resolved by 0.6% Tris-borate-EDTA agarose gel
electrophoresis, and transferred to a Nytran membrane. DNA probes, generated
by PCR, were labeled by using the ECL direct nucleic acid labeling and detection
system (Amersham Pharmacia Biotech, Quebec, Canada), and positive bands
were visualized by chemiluminesence. SagA through SagHI probes were amplified from GAS NZ131 genomic DNA by using primers sagA 1530 and sagA 1688
(Table 2), as well as the sagB, -C, -D, -E, -F, -G, and -HI primer pairs described
previously (38).
Targeted mutagenesis of S. iniae sagB. Targeted mutagenesis of S. iniae sagB
was based on a recently described PCR ligation mutagenesis technique, which
promotes insertion of heterologous DNA and deletion of target DNA (30). The
chromosomal regions upstream (P12) and downstream (P34) of S. iniae sagB
were amplified and ligated to the ERY resistance gene ermB (9) via AscI and
EcoRI restriction endonuclease sites, respectively, incorporated onto the 5⬘ ends
of appropriate primers (Table 2). P12 (946 bp) was amplified by using a primer
630 bp upstream of S. iniae sagA (p1) and 65 bp downstream of S. iniae sagB
(p2-ascI). Likewise, P34 (1,049 bp) was amplified by using a primer pair 23 bp
upstream of the S. iniae sagB stop site (p3-ecoRI) and 807 bp downstream of the
S. iniae sagC start codon (p4). The ermB product was amplified from the gene
cassette (9) template and primers Erm-PA and Erm-PB (30), which have been
described previously (Table 2). All three products were digested with AscI and/or
EcoRI and ligated. The 2,782-bp construct (P12::erm::P34) was amplified from
the ligation mixture by using primers p1 and p4 and was cloned into the TA
vector pCR2.1-TOPO. The insert was directionally cloned (XhoI/HindIII) into
the temperature-sensitive shuttle vector pVE6007⌬, and the resultant plasmid,
pSIsagB.KO.erm, was transformed into S. iniae 9117. CHL-resistant transformants were identified at the permissive temperature for plasmid replication
(30°C). Single-crossover Campbell-type genomic insertions were selected by incubation at a nonpermissive temperature (37°C) while maintaining CHL selection. Selection was relaxed by serial passage at 30°C without antibiotics, and
double-crossover events were identified by negative CHL selection (CHL-susceptible) in broth and the NH phenotype on SBA. Genomic DNA was examined
for ermB, pVE6007⌬, and sagB by PCR and Southern hybridization. During
mutant selection, it was apparent that SI sagB.KO.erm was sensitive to ERY
selection. Sequencing of ermB from plasmid pSIsagB.KO.erm revealed a nucleotide deletion, downstream of the start site, which had created a premature TAA
stop codon.
Complementation of SLS-negative GAS. By using primers SI sagA 1156 and SI
sagA 1352, the entire S. iniae sagA locus, exclusive of the putative promoter, was
amplified from S. iniae 9117 genomic DNA and TA-cloned into pCR2.1-TOPO.
The insert was digested (EcoRV/BamHI) and directionally cloned into the
pDC123 shuttle vector, in the same orientation as the upstream cat promoter.
The resultant construct, pSIsagA, was transformed into competent NZ131
sagA⌬cat. NZ131 sagA⌬cat is an NH, CHL resistant mutant of GAS strain
NZ131 and harbors a precise, in-frame allelic replacement of the GAS sagA gene
with the CHL acetyltransferase (cat) gene. This mutant was constructed by the
same methodology described for mutagenesis of the Streptococcus agalactiae
beta-hemolysin (43) with one exception: the temperature-sensitive targeting vector contained a GAS sag locus sequence where sagA was replaced by cat through
in vivo PCR recombination. The nonpolarity of this mutant was confirmed by
single-gene complementation to full wild-type SLS activity when GAS sagA was
returned on a plasmid vector (V. Datta, R. G. Kansal, and V. Nizet, Abstr. 6th
Ann. Streptococcal Genetics Conf. 2002, abstr. 132, p. 109, 2002).
Transformation of GAS strain NZ131 (wild type) and NZ131 sagA⌬cat with
pDC123 alone provided appropriate experimental controls. Transformants were
selected on SBA containing CHL (4 g/ml), incubated both aerobically and
anaerobically, and screened for a restored beta-hemolytic phenotype. Anaerobic
incubation prevented alpha-hemolysis and potential misinterpretation of SLSnegative control strains. Plasmid DNA recovered from beta-hemolytic isolates
was analyzed by PCR using primers SI sagA 1156 and SI sagA 1352.
Murine model of subcutaneous infection. The virulence of S. iniae strains was
assessed by using a murine model of subcutaneous inoculation as previously
described for GAS (4, 19). Mid-log-phase cultures were washed twice in phosphate-buffered saline (PBS), and 106 CFU was mixed with an equal volume of
sterilized Cytodex beads (Sigma Chemical Co., St. Louis, Mo.) that were suspended in PBS to a concentration of 20 g/ml. This mixture (200 l) was injected
into the right flanks of five to seven hairless, outbred female SKH1 mice (Charles
River Laboratories, Wilmington, Mass.) aged 4 to 5 weeks, weighing 15 to 20 g.

INFECT. IMMUN.
Mice were weighed prior to injection and every 24 h for 3 days. Blood was
collected from a single mouse at 24 h and from the remaining mice at the end of
each trial (72 h) by cardiac puncture and was mixed with citrate-buffered saline.
Representative tissue samples at the injection site were removed from mice and
homogenized in PBS. Viable counts were determined from both sample types.
The experimental procedures performed on the mice were conducted according
to the principles of the Animal Care Committee of Mount Sinai Hospital,
Toronto, Ontario, Canada.
Phagocytosis assay. Resistance to phagocytosis in whole blood was examined
by using a modified protocol of the Lancefield bactericidal assay for GAS (29).
Mid-log-phase bacteria (108 CFU) were washed and serially diluted in PBS.
Bacterial suspensions (100 l) containing 102 to 104 CFU were added to 1 ml of
fresh, heparinized human blood in sterile glass tubes and incubated on an orbital
shaker for 1 h at 37°C. The survival index was calculated as the CFU recovered
after 1 h of incubation divided by the initial inoculum added prior to incubation.
Hemolytic activity assay. The nature of S. iniae cytolysin activity was examined
using a hemolysis assay based on the method previously described for SLS
activity in GAS (4). Whole-cell and supernatant samples were collected from 1
ml of mid-log-phase cultures by centrifugation. Whole-cell fractions were washed
three times and resuspended in 1 ml of PBS. A 1% sheep erythrocyte solution
was prepared in PBS by using erythrocytes washed three times in the same buffer.
Cell and supernatant samples (200 l) were serially diluted across a 96-well
round-bottom microtiter plate in THB, and 100 l of sheep erythrocytes was
added to each well. Plates were incubated for 1 h and centrifuged to pellet both
erythrocytes and bacteria, and 100-l aliquots of supernatant were transferred to
a replica plate. The A450 was measured to determine the release of hemoglobin.
Erythrocytes suspended in PBS plus 0.1% sodium dodecyl sulfate (complete
lysis) or PBS alone (no lysis) were used as controls. Trypan blue (Sigma) at a final
concentration of 13 g/ml was used as an inhibitor of SLS activity.
Nucleotide sequence accession number. The nucleotide sequence data for the
S. iniae sag gene cluster has been submitted to the DDBJ/EMBL/GenBank
databases and was assigned accession number AF465842.

RESULTS
Cytolysin expression in S. iniae. Commensal and diseaseassociated strains were cultured on SBA under aerobic and
anaerobic conditions. Regardless of oxygen tension, all 32
commensal strains exhibited pronounced zones of beta-hemolysis surrounding individual colonies. However, comparable
zones of beta-hemolysis were observed with disease-associated
strains (21) only when they were cultured anaerobically. Under
aerobic conditions, disease-associated strains were largely alpha-hemolytic, with a weak zone of beta-hemolysis surrounding the colonies. Incubation beyond 24 h yielded a thin halo of
beta-hemolysis between the colony and the zone of alphahemolysis, similar to the pattern originally described by Pier
and Madin (42) (Fig. 1). Cytolytic activity, examined by using
a hemolysis assay, was found to be associated with whole-cell
preparations and could be inhibited by addition of the dye
trypan blue (13 g/ml), indicating SLS activity. Hemolytic activity was not observed in supernatants (data not shown).
Tn917 mutagenesis and genomic sequence recovery. To
identify the genomic region responsible for hemolysin expression in S. iniae, the single Tn917 insertion sites in two NH
mutants, SINH1 and SINH3, were mapped by Southern blot
analysis. In SINH3, a 405-bp cloned S. iniae DNA fragment
representing the transposon insertion site shared significant
nucleotide similarity with the junction of the sagG and sagH
genes from the SLS biosynthetic operon in GAS (Fig. 2). For
SINH1, single-primer PCR analysis of flanking DNA revealed
sequences with homology to the complete GAS sagA gene and
part of the sagB gene, localizing the Tn917 insertion to the
region immediately downstream of the start codon of the homologue (Fig. 2).
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Characterization of the sag-like gene cluster in S. iniae.
Southern hybridization with GAS-derived sag probes against
HindIII-digested S. iniae genomic DNA indicated the presence
of sequences in S. iniae homologous to each of the nine genes
in the GAS sag operon. Additionally, the S. iniae genes appeared to be placed in the same genetic order as those in GAS
(data not shown). The genomic DNA between the S. iniae sagB
and sagG open reading frames (ORFs) (⬃4.5 kb) was amplified and sequenced through successive chromosomal walking
steps. Sequence downstream of the S. iniae sagG ORF was
obtained from a bacteriophage  clone, generated in a concurrent study (C. Duncan, unpublished data) using the Lambda
FIX II/XhoI Partial Fill-In Vector kit (Stratagene, La Jolla,
Calif.), as identified by Southern hybridization with an S. iniae
sagG probe. Oligonucleotide primers designed specifically for
each of the nine sag ORFs of the disease-associated S. iniae
strain 9117 yielded products of expected sizes from the representative commensal strain 9066. This finding indicated that
conservation of the sag-like gene cluster in S. iniae was independent of the PFGE genetic profile associated with the capacity of the organism to produce invasive disease (48).
Sequence analysis of the S. iniae sag-like gene cluster. Table
3 lists the ORF sizes and homology with each of the corre-

sponding GAS sag genes. The S. iniae sagA ORF encoded a
predicted 54-amino-acid (aa) peptide exhibiting 73% sequence
identity with SagA of GAS, which contains several features
reminiscent of a bacteriocin prepropeptide (Fig. 3) (38). Conserved features of the two predicted SagA proteins include a
putative leader peptide with a glycine-glycine cleavage site and
a number of target residues (cysteine, serine, and glycine) in
the proposed propeptide, which may serve as targets for posttranslational modification (Fig. 3).
The S. iniae sagB ORF encoded a predicted 316-aa product
with 77% identity to SagB of GAS, and both of these products
shared weak homology with the cytoplasmic modifying enzyme
McbC of E. coli (20). McbC is involved in the posttranslational
modification of McbA, to produce the mature bacteriocin microcin B17, and uses flavin mononucleotide (FMN) as a cofactor (36). A conserved domain in the SagB ORF of S. iniae
(positions 125 to 298) was identified by using the conserved
domain database (RPS-BLAST) in GenBank. By use of default
parameters, the CDD search tool (GenBank) aligned 97% of
this region to a group of nitroreductases (flavoproteins) that
bind FMN noncovalently (Fig. 4). The NADH oxidase (NO) of
Thermus thermophilus and the nitroreductase (NR) of Enterobacter cloacae align most closely with S. iniae SagB (7, 40).

FIG. 2. Map of S. iniae SLS-associated gene cluster. Tn917 insertion points of characterized mutants (SINHI, SINH3, and SI sagB.KO.Tn917),
and the putative promoter (P) and rho-independent terminator (T) regions, are indicated.
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FIG. 1. Photograph depicting the hemolytic phenotypes exhibited by the disease-associated strain 9117 (A) and the commensal strain 9066
(B) of S. iniae cultured on SBA under aerobic conditions. Panel B is representative of the hemolysis exhibited by both disease-associated and
commensal strains cultured anaerobically.
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TABLE 3. Predicted Sag proteins in S. iniae
Gene

Protein length
(aa)

% Identity (% similarity) to
GAS Sag products

sagA
sagB
sagC
sagD
sagE
sagF
sagG
sagH
sagI

54
316
354
453
220
229
307
375
372

73 (80)
77 (85)
78 (87)
82 (87)
60 (75)
52 (70)
75 (84)
81 (89)
74 (84)

Several residues, Ser46, Pro156, Leu158, and Gly159 of T. thermophilus, are directly associated with FMN binding (24) and,
along with neighboring residues, are relatively conserved in
this family of flavoproteins (47). These putative FMN-binding
regions are also relatively conserved in the S. iniae and GAS
SagB proteins and E. coli McbC, specifically Ser46 and Gly159
residues (Fig. 4).
The sagC, sagD, sagE, and sagF ORFs of S. iniae encoded
predicted products with significant amino acid identity to corresponding sag products of GAS yet shared no homology with
other proteins in the GenBank database. As reported for GAS,
the SagG, SagH, and SagI predicted proteins of S. iniae exhibited homology to the components of a family of ATP-binding
cassette (ABC)-type transport systems. These products showed
the greatest homology (47, 22, and 23% amino acid identity,
respectively) to the ABC transport system expressed by Clostridium acetobutylicum (39). By use of the CDD search tool
(RPS-BLAST) in GenBank, 58% (positions 30 to 210) of the
predicted SagG-like protein structure was found to be completely conserved with the ATPase component of the ABC
transporter protein family mentioned above. Inverted-repeat
stem sequences consistent with rho-independent terminators
were found between the sagA and sagB ORFs and immediately
downstream of the sagI ORF of S. iniae (Fig. 2), similar to
those reported for GAS (38).
Targeted mutagenesis of the S. iniae sagB locus. Each of the
nine sag operon genes appears to be required for SLS expression in GAS (38). We chose targeted mutagenesis of S. iniae
sagB to confirm the role of the S. iniae sag locus in SLS expression and to accurately assess the role of SLS in S. iniae

virulence. A plasmid was constructed for deletion of S. iniae
sagB and insertion of ermB, by double-crossover recombination, using the temperature-sensitive vector pVE6007⌬. The
plasmid, pSIsagB.KO.erm, was transformed into S. iniae 9117,
and cultures were monitored for evidence of plasmid integration (i.e., isolates growing on CHL at the nonpermissive temperature for pVE6007⌬). Single-crossover events were identified by PCR using ermB and pVE6007⌬ primers (SK⫹ and
T7). Insertional mutants were continually subcultured at permissive temperatures to enable pVE6007⌬ excision from the
chromosome during homologous recombination. Following
⬃6 subcultures, a CHL-sensitive, NH isolate was recovered.
PCR indicated that the mutant, SI sagB.KO.erm, had retained
the ermB gene but had lost the pVE6007⌬ vector backbone.
The ermB probe hybridized with the expected 6.0-kb region in
both single- and double-crossover mutants (Fig. 5A). Conversely, pVE6007⌬ hybridized with the expected 6.0-kb region
in the single-crossover mutant only, indicating pVE6007⌬ excision from SI sagB.KO.erm. Moreover, only the single-crossover mutant hybridized with a probe generated from S. iniae
sagB (Fig. 5C). Collectively, these results indicated that the loss
of the hemolytic phenotype in SI sagB.KO.erm could be attributed to the replacement of S. iniae sagB by ermB.
Restoration of hemolysis in SLS-negative GAS by use of the
S. iniae sagA locus. To determine whether the S. iniae sagA
gene encodes a functional homologue of the putative GAS
SLS precursor, the NH GAS allelic replacement mutant,
NZ131 sagA⌬cat, was transformed with S. iniae sagA (pSIsagA). Transformants exhibited a restored beta-hemolytic phenotype whether grown aerobically or anaerobically (Fig. 6),
while the mutant strain transformed with the vector alone
remained NH. The extent of beta-hemolysis exhibited by the
complemented mutant NZ131 sagA⌬cat(pSIsagA) was comparable to that observed for the wild-type GAS strain, NZ131,
transformed with the vector alone. Thus, the sagA gene of S.
iniae was sufficient to restore the SLS phenotype in a sagA
mutant of GAS.
Virulence of SI sagB.KO.erm in a murine model. Mice infected with 106 CFU of SI sagB.KO.erm showed signs of lethargy and wasting similar to those of mice infected with the wild
type at 24 h postinoculation. Similarly, a median weight loss of
4.3 g (range, 2.0 to 6.5 g), comparable to that of mice infected
with the wild type (5.0 g; range, 2.0 to 5.5 g), was noted (Fig. 7).

FIG. 3. Amino acid sequence similarity between SagA proteins of S. iniae and GAS. Putative Gly-Gly cleavage sites are underlined, and
residues thought to undergo posttranslational modification are shaded.
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Mice infected with SI sagB.KO.erm (106 CFU) maintained
significant bacteremia over the 72-h trial. One mouse, euthanatized at 24 h postinoculation, harbored 105 CFU/ml in the
blood, and 104 to 105 CFU/ml was recovered from the blood of
the remaining six mice at 72 h. Similar levels of bacteria were
recovered from mice infected with the wild-type strain 9117. SI
sagB.KO.erm was capable of causing bacteremia (105 CFU/ml)
from an inoculum as low as 102 CFU, as previously reported
for strain 9117 (19). Bacteria isolated from the blood of SI
sagB.KO.erm-infected mice remained NH under anaerobic culture conditions, confirming the integrity of the mutant phenotype.
Although the commensal strain 9066 does not induce invasive disease in mice, even at an inoculum as high as 108 CFU
(19), it does give rise to a localized necrotic lesion at the site of
inoculation, as does the disease-associated strain 9117. However, with the latter, mortality due to bacteremia occurs rapidly
and progression of the necrotic lesion cannot be monitored. In
order to examine the role of SLS in necrotic-lesion formation,
we used the NH commensal mutant SI sagB.KO.Tn917, which
contains a Tn917 insertion within the sagB ORF, in the murine
model. Mice were inoculated either with 108 CFU of SI sagB.KO.Tn917 or with one of the wild-type strains 9174 and
9066. Strain 9174 caused necrotic lesions in 60% (3 of 5) of
mice, compared to 100% (5 of 5) necrotic-lesion formation in
9066-infected mice. In contrast, SI sagB.KO.Tn917 did not
cause necrotic lesions in mice (n ⫽ 5). Mice inoculated with
9066, 9174, or SI sagB.KO.Tn917 all experienced weight gains,
with medians of 1.0 g (range, 0.0 to 2.5 g), 1.25 g (range, 1.0 to
3.0 g) and 0.25 g (range, 0.0 to 1.0 g), respectively, as did those

inoculated with Cytodex and no bacteria (1.0 g; range, 0.0 to
2.5 g) (P ⫽ 0.95 by the Wilcoxon signed-rank test). None of
these mice developed bacteremia. Culture of the inoculation
site from SI sagB.KO.Tn917-inoculated mice yielded NH colonies on SBA with or without ERY, confirming the stability of
the mutant in vivo.
Effect of SLS expression on S. iniae resistance to phagocytosis. Disease-associated strains of S. iniae have been found to
be highly resistant to killing by human blood, in contrast to the
marked susceptibility of commensal isolates (19). Following
exposure of the NH mutant SI sagB.KO.erm to whole human
blood, the number of viable CFU recovered (percent survival)
was comparable to that for the wild-type disease-associated
strain 9117. As shown in Fig. 8, 75% of the SI sagB.KO.erm
inoculum was recovered from blood, in comparison to 79%
recovery of 9117. In contrast, the commensal isolate 9066 was
completely susceptible to whole-blood killing, as previously
described (19).
DISCUSSION
Disease-associated strains of S. iniae, represented by a
unique genetic profile, cause soft-tissue infection in humans
and are able to sustain invasive disease in a murine model of
soft-tissue infection (19). However, the precise bacterial factors contributing to disease have not been elucidated. We
hypothesized that the S. iniae cytolysin, responsible for its
hemolytic phenotype, may represent one such virulence determinant. Insertional mutagenesis of a disease-associated strain
of S. iniae and subsequent sequencing steps led to the discovery

FIG. 5. Southern blot analysis of pSIsagB.KO.erm recombination into the S. iniae 9117 genome. Each lane represents HindIII-digested genomic
or plasmid DNA. Lanes: 1, wild type; 2, single-crossover mutant; M, marker; 3, double-crossover mutant; 4, pVE6007⌬ (control); 5, pSIsagB.KO.erm (control). Probes were ermB (A), pVE6007⌬ (B), and sagB from S. iniae (C). Molecular sizes (in kilobases) are indicated to the left of each
image.
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FIG. 4. Amino acid alignment of putative FMN-binding regions of bacterial flavoproteins and SagB. Sequences are derived from the NR of E.
cloacae, NO of T. thermophilus, and bacteriocin-processing enzymes McbC and EpiD from E. coli and S. epidermidis, respectively. Asterisks indicate
conserved residues. Residues directly bound to FMN in T. thermophilus NO are underlined. Boldfaced residues represent putative FMN-binding
regions.
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FIG. 6. Photograph illustrating restoration of the SLS phenotype in
the NH GAS mutant NZ131 sagA⌬cat (left) following complementation with pSIsagA, harboring the sagA ORF from the disease-associated S. iniae strain 9117 (right). Cultures were incubated anaerobically
at 37°C.

that S. iniae cytolytic activity is encoded by a gene cluster that
shares significant genetic similarities with the 9-gene GAS sag
operon for SLS biosynthesis (38). The first gene of this operon,
sagA, encodes a putative bacteriocin-like prepropeptide with
sequence similarity to the microcin B17 precursor (McbA)
from E. coli. Immunological studies have recently provided
convincing evidence that sagA is the structural gene encoding
SLS. Antibodies raised against a synthetic peptide of SagA
effectively abolished the cytolytic activity of SLS (10). The
remaining gene products of the operon are contiguously
aligned (sagB to sagI) and are considered important for the
processing and transport of SagA. In addition, while the GAS
sag operon is both necessary and sufficient for SLS production,
there is evidence that sagA may also possess a regulatory function affecting the expression of SLS and other GAS virulence
factors through a complex mechanism (6, 32, 34).
The discovery of an SLS homologue in S. iniae adds to a
small list of streptococcal pathogens harboring a version of this
potent exotoxin. Human large-colony, beta-hemolytic group C
and group G streptococci, belonging to Streptococcus equisimilis subsp. dysgalactiae, were recently shown to possess saglike genetic loci for SLS biosynthesis (25). Streptococcus equi,
the cause of strangles in horses, produces a beta-hemolysin
with SLS-like characteristics (15). SLS is distinct from the
other GAS hemolysin, SLO, a cholesterol-dependent, oxygenlabile cytolysin encoded by a single gene (21, 27), and the
beta-hemolysin/cytolysin of GBS, encoded by the cylE gene
(43, 45).
Comparative analysis between the GAS and S. iniae sag

INFECT. IMMUN.

FIG. 7. Weight change observed in hairless female mice 72 h after
subcutaneous inoculation with strains of S. iniae. Bars represent median weight gains ⫾ ranges. Mice infected with the disease-associated
S. iniae strain 9117 (shaded bar) or the sagB mutant (open bar) experienced significant weight loss, in contrast to a weight gain observed for
mice inoculated with sterile Cytodex and no bacteria (striped bar)
(0.75 g; range, 0.0 to 2.5 g) (P ⬍ 0.005 by the Wilcoxon signed-rank
test).

clusters revealed significant amino acid similarity and an identical gene arrangement. Additional features shared with GAS
were a putative promoter region upstream of the sagA ORF,
ribosomal binding sites and translational stop codons for each
gene, and two noncoding regions that harbor putative rhoindependent terminators, located between the sagA and sagB

FIG. 8. Resistance to phagocytosis of the disease-associated S.
iniae strain 9117 (shaded bar), the sagB mutant (open bar), and the
commensal strain 9066 (solid bar) in whole blood. Each bar represents
the percentage of viable organisms relative to the initial inoculum
(100%) remaining after 1.0 h of rotation in fresh human blood. Results
are means ⫾ standard deviations.
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ORFs and downstream of the sagI ORF (38). Residues that are
considered important for SagA maturation in GAS are conserved in S. iniae. The Gly-Gly sequence is thought to precede
a cleavage site that would remove the putative leader sequence
and yield a product equivalent to the predicted size of SLS in
GAS (38). The propeptide sequence of S. iniae also contains a
high number of residues (8 cysteines, 3 serines, and 5 glycines)
that are considered precursors for posttranslational modification in GAS SagA (38). Complementation and trypan blue
inhibition studies demonstrated the functional relatedness of
the sagA gene products. When the sagA locus of S. iniae was
cloned and transformed into a sagA allelic replacement mutant
of GAS, cytolytic activity was restored. Therefore, these findings demonstrate that, in addition to conserved amino acid
sequence, the biological activities of the SagA peptides are
similar and that the additional proteins required for processing
and/or transport of SLS do not discriminate between these two
SagA peptides.
The SagB product of S. iniae contains a protein domain
conserved among a group of bacterial flavoproteins, most notably the NR of E. cloacae and the NO of T. thermophilus (7,
40). Furthermore, the FMN-binding regions of T. thermophilus
NO (24) are potentially conserved in other flavoproteins (47)
as well as SagB. The amino acid sequences of the SagB products also share weak homology with McbC of E. coli (20). In
conjunction with McbB and McbD, McbC forms the microcin
B17 synthetase that directs the chemical modification of McbA
prepropeptide amino acids (31). Interestingly, preliminary
studies have suggested that McbC is a flavoprotein in that
recombinant protein is associated with stoichiometric quantities of FMN (36). The bacteriocin epidermin, produced by
Staphylococcus epidermidis, also requires the enzymatic action
of a flavoprotein, EpiD, for posttranslational modification
(28). In addition, at least one of the conserved FMN-binding
motifs mentioned above is present in both McbC and EpiD.
These observations, in combination with the predicted cytoplasmic localization of SagB (38), support the hypothesis that
these conserved regions in SagB are involved in FMN binding
and that SagB contributes to the chemical modification of
SagA. Liu et al. reported elimination of SLS activity in a
transposon Tn916 mutant of GAS deficient in riboflavin biosynthesis (34). Considering that FMN is a direct product of
riboflavin metabolism, a requirement for FMN would provide
the link between SLS activity and riboflavin biosynthesis.
Although the S. iniae cytolysin confers a beta-hemolytic phenotype on SBA, the hemolytic profile of disease-associated
strains is less profound than that of commensal strains when
cultures are grown aerobically. In vitro growth exhibits weak
beta-hemolysis encircling a zone of alpha-hemolysis and can
easily be confused with the alpha-hemolysis of viridans streptococcal species. Yet the extent of cytolysis is equivalent when
disease-associated and commensal strains are cultured anaerobically. The nucleotide sequence of sagA, including the promoter region and ⬎600 bp upstream of the sagA ORF, is
identical in disease-associated and commensal isolates (data
not shown). Following complementation of an NH strain of
GAS with the S. iniae sagA gene from a disease-associated
strain, a beta-hemolytic phenotype resulted, regardless of oxygen tension. These findings suggest that a regulatory mechanism, rather than structural differences in SagA, affects the
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oxygen-dependent expression of SLS in disease-associated
strains. In GAS, the CovR-CovS two-component regulatory
system and the negative regulators Nra and RofA negatively
influence sagA transcription (2, 14, 37), and rofA is also affected by oxygen conditions (16, 17). A small number of strains
expressing hemolytic phenotypes opposite to those described
for their genotypes (disease associated versus commensal)
have been identified. These include two commensal strains and
the ATCC type strain 29178, expressing the alpha/beta-hemolytic phenotype, as well as two constitutively beta-hemolytic
disease-associated strains, all grown under aerobic and anaerobic conditions (data not shown). Although the selective advantage that this oxygen-dependent SLS phenotype confers on
S. iniae is not immediately apparent, these observations lend
further support to the hypothesis that SLS expression is under
some degree of regulation.
By use of a murine model of subcutaneous infection, SLS
activity in GAS has been linked to tissue necrosis (4). Recent
work showed that targeted mutagenesis of each of the sag
genes generated an NH mutant, while mutagenesis immediately downstream of the operon did not abolish hemolysis,
demonstrating a direct link between the hemolytic phenotype
and the defined sag locus (38). When a GAS sagA allelic
replacement mutant (NZ131 sagA⌬cat) was examined in a
murine model of subcutaneous infection, a complete attenuation of necrotic-lesion formation, similar to that in previous
studies (4), was observed (unpublished data), emphasizing the
importance of sagA expression in GAS virulence. By using a
disease-associated strain of S. iniae, a sagB insertion-deletion
mutant was generated to examine the role of SLS in the virulence of this pathogen. Previous work with S. iniae demonstrated that disease-associated strains, in stark contrast to commensal isolates, established bacteremic infection in the murine
model following subcutaneous inoculation and were highly resistant to phagocytic killing in whole human blood (19). Interestingly, the SLS-deficient SI sagB.KO.erm mutant was also
able to cause invasive disease in this model, even at low inocula, with no evident signs of attenuated virulence in comparison to that with the wild type. Furthermore, this mutant remained resistant to whole-blood killing in vitro. From these
studies, it is apparent that the contribution of S. iniae SLS to
bacteremia and resistance to phagocytosis is negligible. It was
previously reported that disease-associated and commensal
strains of S. iniae can elicit localized necrosis in the murine
model, similar to that elicited by GAS, if a higher inoculum of
108 CFU is used (19). However, mice infected with diseaseassociated strains at this dose are at risk of terminal disease,
likely due to the invasiveness of these strains. Thus, we examined necrotic-lesion formation caused by a commensal isolate
and its SLS-deficient counterpart. In contrast to the commensal wild-type isolate, which caused necrotic lesions in 60% of
animals, the SLS-deficient mutant, SI sagB.KO.Tn917, did not
cause localized cell damage in mice. These results suggest that
SLS of S. iniae contributes to tissue damage but not to bacteremia.
In summary, we have identified an SLS-associated gene cluster within the chromosome of S. iniae with strong homology to
that of GAS and demonstrated the requirement for SLS in
causing tissue damage in a mammalian model. While SLS does
seem to contribute to virulence by promoting local tissue ne-
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crosis, it does not play a critical role in the establishment of
bacteremia in mice. However, S. iniae infection in fish is characterized by meningoencephalitis, and SLS may be required
for brain endothelial-cell injury. Future studies will test this
hypothesis in a fish infection model of meningoencephalitis.
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